Halozyme Therapeutics (HALO) EV to FCF (2017 - 2026)
Halozyme Therapeutics' (HALO) EV to FCF was 10.78 for Q2 2026, up 4.7% from 10.30 a year earlier but down 1.9% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EV to FCF (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' EV to FCF came in at 9.34, up 41.9% year-over-year; for FY2025, it was 12.08, up 6.9% from FY2024.
- By year, EV to FCF came in at 11.30 in FY2024 (-3.0%), 11.65 in FY2023 (-62.6%), 31.14 in FY2022 (+93.2%) and 16.12 in FY2021 (-84.4%).
- Five-year quarterly EV to FCF spans a low of 10.30 in Q2 2025 and a high of 31.14 in Q4 2022.
- Year over year, EV to FCF gained in four of the last eight quarters, with an average decline of 1.0%.
- The high point for year-over-year EV to FCF in five years was Q4 2022 (growth of 93.2%); the low point was Q4 2021 (a decline of 84.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 11.00 (Q1 2026), 12.08 (Q4 2025) and 13.14 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.78 |
| Mar 31, 2026 | 11.00 |
| Dec 31, 2025 | 12.08 |
| Sep 30, 2025 | 13.14 |
| Jun 30, 2025 | 10.30 |
| Mar 31, 2025 | 14.34 |
| Dec 31, 2024 | 11.30 |
| Sep 30, 2024 | 16.84 |
| Jun 30, 2024 | 14.93 |
| Mar 31, 2024 | 11.12 |
| Dec 31, 2023 | 11.65 |
| Sep 30, 2023 | 12.90 |
| Jun 30, 2023 | 15.05 |
| Mar 31, 2023 | 18.03 |
| Dec 31, 2022 | 31.14 |
| Sep 30, 2022 | 21.39 |
| Jun 30, 2022 | 20.16 |
| Mar 31, 2022 | 16.41 |
| Dec 31, 2021 | 16.12 |
| Sep 30, 2021 | 18.57 |
API Access
Halozyme Therapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();